Relationship between glycaemic variability and hyperglycaemic clamp-derived functional variables in (impending) type
Annelien Van Dalem1, Simke Demeester1, Eric V Balti1
1Diabetes Research Center, Vrije Universiteit Brussel, Laarbeeklaan 100, 1090, Brussels, Belgium.
Diabetologia
|September 28, 2015
Summary
Continuous glucose monitoring (CGM) and glucose disposal rate better detect type 1 diabetes progression than traditional measures. These findings support developing CGM-based criteria for monitoring and clinical trials.
Area of Science:
- Endocrinology
- Metabolic Disease Research
- Diabetes Pathophysiology
Background:
- Type 1 diabetes (T1D) progression from preclinical stages involves complex changes in beta cell function and insulin action.
- Continuous glucose monitoring (CGM) and self-monitoring of blood glucose (SMBG) provide data on glycemic variability (GV).
- Identifying reliable markers for early detection of T1D development is crucial for intervention.
Purpose of the Study:
- To evaluate if glycemic variability (GV) measures from CGM and SMBG can substitute or enhance traditional markers of beta cell function and insulin action.
- To assess the utility of GV in detecting the transition from preclinical stages to type 1 diabetes.
- To compare the diagnostic efficiency of different glycemic monitoring methods in high-risk individuals.
Main Methods:
- Twenty-two autoantibody-positive first-degree relatives (FDRs) at high risk for T1D underwent CGM, hyperglycaemic clamp tests, and oral glucose tolerance tests (OGTT).
- Beta cell function was assessed via C-peptide release (AUC5-10 min and AUC120-150 min) during clamp tests.
- Insulin resistance was measured by glucose disposal rate (M 120-150 min); GV was analyzed from CGM and SMBG data.
Main Results:
- The glucose disposal rate (M 120-150 min) below the 10th percentile of controls showed 86% efficiency in distinguishing normoglycemic FDRs from those with dysglycemia.
- CGM-derived GV measures demonstrated higher efficiency (77-82%) in detecting dysglycemia compared to SMBG (73%).
- Combined CGM measures and the glucose disposal rate exhibited equal diagnostic efficiency (86%), outperforming C-peptide measures (59-68%).
Conclusions:
- CGM-derived GV and glucose disposal rate are superior to SMBG and C-peptide AUC measures in identifying individuals with impending dysglycemia or type 1 diabetes.
- These findings suggest the potential for developing minimally invasive, CGM-based monitoring criteria.
- CGM-based metrics could serve as valuable outcome measures in clinical trials for type 1 diabetes progression.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
5.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.6K
Diabetes Mellitus: Overview and Type I Subtype
6.0K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.0K
Diabetes: Symptoms, Diagnosis, and Complications
2.8K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.8K
Pathophysiology of Diabetes
4.4K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.4K
Glucose Homeostasis: Regulation of Blood Glucose
5.4K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
5.4K
Hormones Regulating Blood Glucose
8.6K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
8.6K


